Development Pipeline

Explore our broad clinical development program.

Smart Drug Design

We strive to develop best-in-class medicines that target multiple pathways and work in combination regimens.

Accelerating Innovation Through Partnership

High-impact relationships maximize results and expand possibilities.

Development Pipeline

Explore our broad clinical development program.

Smart Drug Design

We strive to develop best-in-class medicines that target multiple pathways and work in combination regimens.

Accelerating Innovation Through Partnership

High-impact relationships maximize results and expand possibilities.

Company Statement on COVID-19

Exelixis is actively monitoring the global COVID-19 pandemic, and remains steadfast in our commitment to the health and safety of our patients, customers, employees and local communities.

Cancer is our Cause

We strive to develop effective, tolerable and durable
treatments to help patients with cancer thrive.

Tackling Difficult-to-Treat Cancers

To date, we have three medicines available to treat certain types of kidney, liver and thyroid cancers and advanced melanoma.

Join Us

At Exelixis, everyone leads in our collective quest to drive for results so patients can have hope for remission.

IMPORTANT NOTICE REGARDING EXELIXIS AT HEALTHCARE CONFERENCES IN MARCH

Due to the fluidity of the coronavirus situation, Barclays has converted its Global Healthcare Conference into a “virtual” meeting, and Exelixis’ fireside chat has been rescheduled for later in the morning on Tuesday, March 10th to accommodate the change in logistics. In addition, Oppenheimer has cancelled all of the presentations for its upcoming 30th Annual Healthcare Conference, which was scheduled to take place March 17-18th; as a result, Exelixis will no longer be presenting at the meeting.

RECENT EVENTS